[Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it]
- PMID: 18575451
[Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it]
Abstract
Objective: To compare the platelet enrichment ratio of platelet-rich plasma (PRP) prepared by different centrifuge methods and to compare the concentration of growth factors released from autologous platelet-rich gel (APG) with the whole blood.
Methods: Thirteen diabetic patients with refractory skin lesions were enrolled in APG treatment. (1) Three kinds of centrifuge methods were selected for PRP by 11 diabetic patients: A (n = 6): 529 x g for 4 minutes in the first centrifuge and 854 x g for 6 minutes in the second centrifuge; B (n = 5): 313 x g for 4 minutes in the first centrifuge and 1,252 x g for 6 minutes in the second centrifuge; C (n = 5): 176 x g for 5 minutes in the first centrifuge and 1,252 x g for 5 minutes in the second centrifuge. Platelet counted on the whole blood and PRP was determined. The APG, produced by combining the PRP with thrombin and calcium gluconate (10:1) was used by patients. (2) PDGF-BB, TGF-beta1, VEGF, EGF, and IGF-1 were measured in the APG and the whole blood using the enzyme-linked immunosorbent assay method.
Results: (1) The average platelet concentration was higher in group B [(1,363.80 +/- 919.74) x 10(9)/L] than in groups A [(779.67 +/- 352.39) x 10(9)/L)] and C [(765.00 +/- 278.78) x 10(9)/L] and the platelet recovery rate was 75.2% +/- 21.0% in group B. (2) The concentration of growth factors all increased with the increasing platelet number. On average, for the whole blood as compared with APG, the PDGF-BB concentration increased from (145.94 +/- 133.24) pg/mL to (503.81 +/- 197.86) pg/mL (P < 0.05); TGF-beta1 concentration increased from (3.31 +/- 2.27) ng/mL to (5.67 +/- 4.80) ng/mL (P < 0.05); IGF-1 concentration increased from (14.54 +/- 35.34) ng/mL to (110.56 +/- 84.36) ng/mL (P < 0.05); and EGF concentration increased from (160.73 +/- 71.10) pg/mL to (265.95 +/- 138.43) pg/mL (P < 0.05). No increase was found for VEGF (P > 0.05). (3) There was positive correlation between the platelet concentration and PDGF-BB and TGF-beta1 (r = 0.627, r = 0.437, P < 0.05). (4) Thirteen diabetic repractory dermal ulcers received APG treatment for 18 times, 9 ulcers (69.2%) and 10 sinuses (88.3%) were cured at the end of 12-week treatment.
Conclusion: The method of group B is the best centrifuge method. A variety of growth factors are detected and released from the platelets at significant levels in APG. There is positive correlation between the platelet concentration and PDGF-BB and TGF-beta1.
Similar articles
-
[Preparation of platelet-rich plasma gel and its effect on skin flap survival of rat].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Jan;26(1):64-9. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012. PMID: 22332522 Chinese.
-
Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.Int J Oral Maxillofac Implants. 2002 Mar-Apr;17(2):184-90. Int J Oral Maxillofac Implants. 2002. PMID: 11958400
-
[The preliminary application of autologous platelet-rich gel used to treat refractory diabetic dermal ulcer].Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):900-3. Sichuan Da Xue Xue Bao Yi Xue Ban. 2007. PMID: 17953386 Chinese.
-
[Application of autologous platelet-rich gel to refractory chronic diabetic cutaneous ulcers].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Apr;21(4):426-9. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007. PMID: 17546893 Review. Chinese.
-
Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery.Ortop Traumatol Rehabil. 2007 May-Jun;9(3):227-38. Ortop Traumatol Rehabil. 2007. PMID: 17721419 Review. English, Polish.
Cited by
-
Autologous Platelet-Rich Gel Treatment of Chronic Nonhealing Ulcerated Tophaceous Gout.Indian J Dermatol. 2020 Mar-Apr;65(2):141-144. doi: 10.4103/ijd.IJD_157_18. Indian J Dermatol. 2020. PMID: 32180603 Free PMC article.
-
Quantification of Growth Factors and Fibronectin in Diverse Preparations of Platelet-Rich Plasma for the Treatment of Ocular Surface Disorders (E-PRP).Transl Vis Sci Technol. 2020 May 21;9(6):22. doi: 10.1167/tvst.9.6.22. eCollection 2020 May. Transl Vis Sci Technol. 2020. PMID: 32821519 Free PMC article.
-
Case report: The use of PRP in the treatment of diabetic foot: case series and a review of the literature.Front Endocrinol (Lausanne). 2023 Dec 18;14:1286907. doi: 10.3389/fendo.2023.1286907. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38170077 Free PMC article. Review.
-
The Effect of Autologous Platelet-Rich Gel on the Dynamic Changes of the Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Expression in the Diabetic Chronic Refractory Cutaneous Ulcers.J Diabetes Res. 2015;2015:954701. doi: 10.1155/2015/954701. Epub 2015 Jun 28. J Diabetes Res. 2015. PMID: 26221614 Free PMC article.
-
Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro.J Diabetes Res. 2013;2013:269527. doi: 10.1155/2013/269527. Epub 2013 Feb 28. J Diabetes Res. 2013. PMID: 23671863 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous